Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary J. Kuhn currently holds 63,779 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary J. Kuhn has been a net seller of TLCR stock. They have purchased $0 and sold $6.5M worth of shares.
Mary J. Kuhn's most recent insider trade was on Jun 1, 2011, when they sold 63,779 shares at $0.00 per share.
Mary J. Kuhn serves as Executive at Talecris Biotherapeutics Holdings Corp. (TLCR). They have executed 16 insider transactions totaling $6.5M over their tenure at the company.
Mary J. Kuhn holds the position of Executive at Talecris Biotherapeutics Holdings Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Mary J. Kuhn has shown a selling trading pattern, with $0 in total purchases and $6.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mary J. Kuhn was on Feb 1, 2011, when they sold $1.3M worth of TLCR shares. This transaction involved 54,697 shares at $24.36 per share.
Mary J. Kuhn currently owns 63,779 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary J. Kuhn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary J. Kuhn has 16 Form 4 filings on record as an insider at Talecris Biotherapeutics Holdings Corp..
Set alerts for Mary J. Kuhn and 40,000+ other insiders.